NANOEX Trademark
Trademark Overview
On Monday, June 30, 2025, a trademark application was filed for NANOEX with the United States Patent and Trademark Office. The USPTO has given the NANOEX trademark a serial number of 99259207. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, May 18, 2026. This trademark is owned by Kaigene, Inc.. The NANOEX trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:
Pharmaceutical and therapeutic preparations, namely, a drug formulation using protein degradation for use in treating immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Biochemical preparations for medical use for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Proteins, protein fragments, and protein conjugates all for use in the manufacture of pharmaceutical preparations for treatment of immunologic diseases, particularly autoimmune diseases
Chemical preparations for scientific purposes; Molecules for use in industry, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for use in science, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for molecular biology, other than for medical or veterinary use, namely, protein-modulating molecules for use in the pharmaceutical industry
General Information
| Serial Number | 99259207 |
| Word Mark | NANOEX |
| Filing Date | Monday, June 30, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, May 18, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical and therapeutic preparations, namely, a drug formulation using protein degradation for use in treating immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Biochemical preparations for medical use for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Proteins, protein fragments, and protein conjugates all for use in the manufacture of pharmaceutical preparations for treatment of immunologic diseases, particularly autoimmune diseases |
| Goods and Services | Chemical preparations for scientific purposes; Molecules for use in industry, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for use in science, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for molecular biology, other than for medical or veterinary use, namely, protein-modulating molecules for use in the pharmaceutical industry |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 30, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Kaigene, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rockville, MD 20850
US |
Trademark Events
| Event Date | Event Description |
| Monday, June 30, 2025 | NEW APPLICATION ENTERED |
| Monday, June 30, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, November 4, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 18, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, November 18, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 18, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 18, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 13, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, February 13, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, May 18, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 18, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 18, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 26, 2026 | ASSIGNED TO EXAMINER |
